or Try an Advanced Search...

    Combination Drugs Stocks List

    Symbol Grade Name % Change
    ABBV A AbbVie Inc. -0.26
    INVA B Innoviva, Inc. 0.98
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids

    Related ETFs - A few ETFs which own one or more of the above listed Combination Drugs stocks.

    Symbol Grade Name Weight
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.94
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    PJP B PowerShares Dynamic Pharmaceuticals 8.83
    FDL A First Trust Morningstar ETF 8.37
    MEDX D Horizon Kinetics Medical ETF 7.89
    View all Combination Drugs ETFs...
    Compare ETFs
    Compare BOTZ to FDL Compare BOTZ to HDLB Compare HDLB to MEDX

        Combination Drugs Stocks Recent News

        Date Stock Title
        Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
        Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
        Oct 1 ABBV AbbVie to Host Third-Quarter 2024 Earnings Conference Call
        Sep 30 ABBV AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
        Sep 30 ABBV AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
        Sep 30 ABBV Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
        Sep 30 ABBV Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
        Sep 30 ABBV 15 Best Dividend Stocks for Lifelong Passive Income
        Sep 30 INVA Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
        Sep 29 ABBV Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
        Sep 29 ABBV Is AbbVie Inc.'s (NYSE:ABBV) ROE Of 78% Impressive?
        Sep 29 ABBV AbbVie: Dividend Discount Model Suggests Large Valuation Risks
        Sep 27 ABBV 15 Unhealthiest Countries in Latin America
        Sep 27 ABBV Bristol Cobenfy approval draws optimism from Street, though with caveats
        Sep 27 ABBV ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
        Sep 27 ABBV AbbVie submits BLA for antibody-drug conjugate Teliso-V for NSCLC
        Sep 27 ABBV AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
        Sep 27 ABBV Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
        Sep 27 ABBV Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
        Sep 27 ABBV AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids
        Combination Drugs

        Combination drugs are medications that contain two or more active ingredients in a single dosage form. These drugs are used to treat a variety of conditions, such as high blood pressure, diabetes, and asthma. Combination drugs can be more effective than taking multiple medications, as they can reduce the number of pills a patient needs to take and may also reduce side effects.

        Browse All Tags